控股股东2120万股再上法拍台、过半持股仍被冻结，ST晨鸣前三季度收入却增逾两倍

yun2025

控股股东2120万股再上法拍台、过半持股仍被冻结，ST晨鸣前三季度收入却增逾两倍

Protagonist Therapeutics, Inc.三季度扭亏为盈，季度营收2.74亿美元

Protagonist Therapeutics, Inc.（PTGX）公布截至9月底的经营数据。第三季度，公司录得2.74亿美元营业收入，比上年同期的471.2万美元增加2.7亿美元，增幅为5723.64%。按归属于母公司的净损益计算，当季盈利2.2亿美元，上年同季亏损3933.9万美元。本季摊薄后每股收益3.07美元，一年前为负0.62美元。

从1月至9月，公司累计实现收入5.44亿美元，与去年同期的3857.9万美元相比增长1310.75%。前九个月归属于母公司的盈利3.87亿美元，去年同期为亏损8576.5万美元。同期经营活动产生的现金为净流入1.47亿美元，上年同期为净流入9464.6万美元。

研发支出方面，三季度投入4127.4万美元，比上年同期的4000.3万美元增长3.18%，相当于当季营收的15.04%。

https://v.youku.com/v_show/id_XNjU3ODYyODg0NA==.html
https://v.youku.com/v_show/id_XNjU4ODMwMzcwNA==.html
https://v.youku.com/v_show/id_XNjU4ODMwMzY4NA==.html
https://v.youku.com/v_show/id_XNjU4ODMwNDk4OA==.html
https://v.youku.com/v_show/id_XNjU4ODMwMzYxMg==.html
https://v.youku.com/v_show/id_XNjU4ODMwNDgxMg==.html
https://v.youku.com/v_show/id_XNjU4ODMwMDc5Mg==.html
https://v.youku.com/v_show/id_XNjU3ODYyMjk1Mg==.html
https://v.youku.com/v_show/id_XNjU3ODYxOTgxNg==.html
https://v.youku.com/v_show/id_XNjU3ODYyMTI5Ng==.html
https://v.youku.com/v_show/id_XNjU3ODYxODAxNg==.html
https://v.youku.com/v_show/id_XNjU3ODYyNDIyNA==.html
https://v.youku.com/v_show/id_XNjU3ODYxOTYyNA==.html
https://v.youku.com/v_show/id_XNjU3ODYxNzk2NA==.html
https://v.youku.com/v_show/id_XNjU3ODYxOTUwNA==.html
https://v.youku.com/v_show/id_XNjU3ODYyNTcxNg==.html
https://v.youku.com/v_show/id_XNjU3ODYyNDEzMg==.html
https://v.youku.com/v_show/id_XNjU3ODYyNTcxMg==.html
https://v.youku.com/v_show/id_XNjU3ODYxNjU1Mg==.html
https://v.youku.com/v_show/id_XNjU3ODYyNDA4OA==.html
https://v.youku.com/v_show/id_XNjU4ODI5ODk3Ng==.html
https://v.youku.com/v_show/id_XNjU3ODYxNTE5Ng==.html
https://v.youku.com/v_show/id_XNjU3ODYxNzc5Ng==.html
https://v.youku.com/v_show/id_XNjU4ODMwMDI4OA==.html
https://v.youku.com/v_show/id_XNjU4ODMwMTY5Mg==.html
https://v.youku.com/v_show/id_XNjU3ODYxMDM0OA==.html
https://v.youku.com/v_show/id_XNjU4ODI5ODgzMg==.html
https://v.youku.com/v_show/id_XNjU3ODYyMDgyMA==.html
https://v.youku.com/v_show/id_XNjU3ODYyMDgxNg==.html
https://v.youku.com/v_show/id_XNjU3ODYxMzQxNg==.html
https://v.youku.com/v_show/id_XNjU4ODI5NzU0NA==.html
https://v.youku.com/v_show/id_XNjU4ODMwMDAzMg==.html
https://v.youku.com/v_show/id_XNjU3ODYxMDE2NA==.html
https://v.youku.com/v_show/id_XNjU3ODYxMTcyNA==.html
https://v.youku.com/v_show/id_XNjU3ODYxNjA0MA==.html
https://v.youku.com/v_show/id_XNjU3ODYwODQ4OA==.html
https://v.youku.com/v_show/id_XNjU4ODI5ODQzNg==.html
https://v.youku.com/v_show/id_XNjU4ODI5ODQyOA==.html
https://v.youku.com/v_show/id_XNjU3ODYwNjc5Mg==.html
https://v.youku.com/v_show/id_XNjU3ODYwOTgzMg==.html
https://v.youku.com/v_show/id_XNjU3ODYwODI1Mg==.html
https://v.youku.com/v_show/id_XNjU3ODYxNDQ4NA==.html
https://v.youku.com/v_show/id_XNjU3ODYxNDQ2NA==.html
https://v.youku.com/v_show/id_XNjU4ODI5NzA4NA==.html
https://v.youku.com/v_show/id_XNjU3ODYwODE5Ng==.html
https://v.youku.com/v_show/id_XNjU3ODYxMjgyOA==.html
https://v.youku.com/v_show/id_XNjU3ODYwMjM1Ng==.html
https://v.youku.com/v_show/id_XNjU3ODYxMTI2OA==.html
https://v.youku.com/v_show/id_XNjU4ODI5NjkzNg==.html
https://v.youku.com/v_show/id_XNjU4ODI5NTc0OA==.html